vimarsana.com
Home
Live Updates
POXEL SA: Poxel Announces its Participation at Investor Conf
POXEL SA: Poxel Announces its Participation at Investor Conf
POXEL SA: Poxel Announces its Participation at Investor Conferences in October 2021
Regulatory News: POXEL SA (Euronext POXEL FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology,
Related Keywords
China ,
Boston ,
Massachusetts ,
United States ,
Taiwan ,
Japan ,
Tokyo ,
South Korea ,
France ,
Sumitomo Dainippon Pharma ,
Arthur Rouill ,
Thomas Kuhn ,
Valeria Fisher ,
Catherine David ,
Anne Renevot ,
Trophic Communications ,
Regulatory News ,
Japan Poxel ,
Sumitomo Dainippon ,
Southeast Asian ,
Euronext Paris ,
Relations Communication Manager ,
Relations Communication Director ,
Vice President ,
Investor Relations Communication ,
Media France ,
Poxel ,
Troxel ,
Nnounces ,
Participation ,
Investor ,
Conferences ,
October ,
021 ,